But abstinence can be a high bar akin to demanding that an antidepressant create complete remission of despair or that an analgesic entirely remove pain. Recognizing this limitation, the FDA encourages builders of opioid2 and stimulant3 use dysfunction drugs to debate with FDA substitute techniques